FRLN — Freeline Therapeutics Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Freeline Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	16.1	73.7	230	118	47.3
Net Total Accounts Receivable
Net Total Receivables	8.99	11.5	16.1	2.21	1.23
Prepaid Expenses
Total Other Current Assets
Total Current Assets	26.1	89	258	128	67.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.73	7.27	8.61	9.91	15
Net Intangible Assets
Other Long Term Assets
Total Assets	32.1	97.4	269	141	86.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.16	12.4	18.8	20.7	31
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.16	12.4	18.8	20.7	34.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	23	85	250	120	52.4
Total Liabilities & Shareholders' Equity	32.1	97.4	269	141	86.6
Total Common Shares Outstanding